GTS Securities’s Vaxart VXRT Stock Holding History

GTS Securities’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,800	Closed	-$14K	–	4358
2024 Q1	$14K	Sell	10,800 -58,200	-84%	-$61K	﹤0.01%	3709
2023 Q4	$39.5K	Sell	69,000 -2,300	-3%	-$1.59K	﹤0.01%	3855
2023 Q3	$53.8K	Buy	+71,300	New	+$54.2K	﹤0.01%	3692

Other funds holding VXRT

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GTS Securities's VXRT Position: Q4 2024 in Review

GTS Securities sold out of Vaxart (VXRT) in Q4 2024, closing a stake of 32,670 shares — an estimated $27.7K sold.

GTS Securities first reported a position in VXRT in Q1 2024 and held it in 3 quarters. The position peaked at $32K in Q2 2024. 93 funds tracked by Wall St. Rank hold VXRT as of Q4 2024.

GTS Securities reported no remaining Vaxart position as of Q4 2024 after selling out during the quarter.
GTS Securities sold 32,670 Vaxart shares in Q4 2024, an estimated $27.7K.
GTS Securities first reported a position in Vaxart in Q1 2024 and held it in 3 quarters.
GTS Securities's Vaxart position peaked at $32K in Q2 2024.
93 funds tracked by Wall St. Rank held Vaxart as of Q4 2024.

Based on GTS Securities's 13F filing for Q4 2024, filed 18 Feb 2025.